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Following the article by De Thomasson [1], we wish to
eport a new case of pyoderma gangrenosum (PG) occurring
fter hip surgery.
An 81-year-old man with a history of unclassiﬁ-
ble myelodysplastic syndrome (MDS), not treated with
ematopoietic growth factors, was hospitalized in the ortho-
edic surgery department for gamma-nail osteosynthesis of
pertrochanteric fracture of the left femur caused by a
all. Progression was marked by the appearance of a moder-
tely painful ulcerated lesion 3 days after the operation,
rogressively and rapidly spreading in a centrifugal man-
er, measuring 27× 17 cm, with a purulent base limited by
n active and detaching reddish-purple edge (Fig. 1). The
atient’s temperature was 38 ◦C and the CRP was 150mg/L.
n D8, empirical antibiotic therapy was initiated, with no
mprovement. After 6 days of antibiotic treatment, with
uspected sepsis caused by the osteosynthesis material, it
as decided to reoperate for surgical cleaning and lavage.
uperﬁcial and deep bacteriological samples of the surgical
ite were negative. The biopsies of the ulcerated cutaneous
esion showed extended pyocytes with abnormal polynuclear
ells ﬁstulating at the skin, suggesting a septic process but
ith no infectious agent, compatible with an abscess. Given
he lack of improvement with large-spectrum antibiotic
herapy, the diagnosis of PG was raised and corticotherapy
nitiated at 1mg/kg per day of prednisone for 15 days with
omplete healing after 4 weeks.
This is the third case of PG described, after hip
urgery (arthroplasty) [1,2] and osteosynthesis (the present
atient). The clinical aspect of PG corresponds to the
lcerated form, which is the most classical form, initially
escribed by Brunsting [3]. In a few days, the centrifugal
utaneous ulceration reached several centimeters in size,
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oi:10.1016/j.otsr.2011.10.004igure 1 Vast cutaneous ulceration surrounded by an inﬂam-
atory fold at the surgical site.
urrounded by a reddish-purple inﬂammatory fold charac-
eristic of PG, which should suggest this diagnosis. The
istology is nonspeciﬁc. The existence of MDS in this patient
nd the inefﬁcacy of the antibiotic therapy oriented the
iagnosis toward PG. Indeed, in 50—80% of PG cases are
ost often associated with digestive tract diseases but
arely hemopathies such as monoclonal IgA gammopathy and
DS [4,5]. The short time between PG onset and osteosyn-
hesis challenges the surgery rather than the MDS in our
pinion, which may nevertheless have played a support-
ng role. Corticotherapy was rapidly effective and healing
ith no sequelae was obtained after 15 days of pred-
isone at 1mg/kg per day, whereas in approximately one
ut of two cases corticotherapy in PG associated with
ther diseases is continued for several months: a mean 4
onths with sometimes addition of an immunosuppressant
r immunomodulator treatment [6]. With the frequency of
DS increasing with age (incidence between 70 and 80 cases
er 100,000 inhabitants older than 80 years of age) [7] and
he high risk of fracture in this elderly population should
ake the orthopedic surgeon vigilant with any extensive
lcerated lesion of the surgical site, which should not be
istaken for sepsis.
.
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